UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	November 4, 2024

Accession Number:	0001193125-24-249236
Submission Type:	POS AM
CIK: 0001733257 Company Name: Finch Therapeutics Group, Inc. File Number: 333-265173